Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gehan Abd-Elfatah Tawfeek & Suzan Alhassanin. (2018) HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome. Immunological Investigations 47:3, pages 315-325.
Read now
Read now
Wei-Hua Yan. (2010) HLA-G expression in hematologic malignancies. Expert Review of Hematology 3:1, pages 67-80.
Read now
Read now
Ana Paula de Souza & Cristina Bonorino. (2009) Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses. Expert Review of Anticancer Therapy 9:9, pages 1317-1332.
Read now
Read now
Articles from other publishers (43)
L. M. Parra, B. G. C. Sartori, D. R. Fernandes, L. R. V. Fachin, M. R. S. Nogueira, A. F. F. Belone, A. J. F. Nunes & F. C. Souza-Santana. (2022) HLA-G expression in Merkel cell carcinoma and the correlation with Merkel cell polyomavirus infection. Immunogenetics 75:2, pages 81-89.
Crossref
Crossref
Andrezza Telles Westin, Luiz Gustavo Gardinassi, Edson Garcia Soares, João Santana Da Silva, Eduardo Antonio Donadi & Cacilda Da Silva Souza. (2021) HLA-G, cytokines, and cytokine receptors in the non-aggressive basal cell carcinoma microenvironment. Archives of Dermatological Research 314:3, pages 247-256.
Crossref
Crossref
Ondřej Vaněk, Barbora Kalousková, Celeste Abreu, Shiva Nejadebrahim & Ondřej Skořepa. 2022. Immunotherapeutics. Immunotherapeutics
91
133
.
Sony Kadiam, Thirunavukkarasu Ramasamy, Revathi Ramakrishnan & Jayalakshmi Mariakuttikan. (2020)
Association of
HLA-G
3'UTR 14-bp Ins/Del polymorphism with breast cancer among South Indian women
. Journal of Clinical Pathology 73:8, pages 456-462.
Crossref
Crossref
Meysam Moghbeli. (2019) Genetic and molecular biology of breast cancer among Iranian patients. Journal of Translational Medicine 17:1.
Crossref
Crossref
Yuying Zhang, Xin Jin & Jie Wang. (2019) miR‑148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑G expression. Molecular Medicine Reports.
Crossref
Crossref
Junaid Raja, Johannes M. Ludwig, Scott N. Gettinger, Kurt A. Schalper & Hyun S. Kim. (2018) Oncolytic virus immunotherapy: future prospects for oncology. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Padmanee Sharma, Sumit K. Subudhi, Karl Peggs, Sangeeta Goswami, Jianjun Gao, Sergio Quezada & James P. Allison. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine
1
23
.
Jinbao Sun, Haipeng Chu, Jianghai Ji, Gaoxiang Huo, Qinglei Song & Xue Zhang. (2016) Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer. International Journal of Oncology.
Crossref
Crossref
Can Küçük, Xiaozhou Hu, Qiang Gong, Bei Jiang, Adam Cornish, Philippe Gaulard, Timothy McKeithan & Wing C. Chan. (2016) Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma. The American Journal of Pathology 186:6, pages 1435-1441.
Crossref
Crossref
Mehdi Haghi, Mohammad Ali Hosseinpour Feizi, Majid Sadeghizadeh & Abbas Sahebghadam Lotfi. (2015) 14-bp Insertion/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran. Asian Pacific Journal of Cancer Prevention 16:14, pages 6155-6158.
Crossref
Crossref
Malgorzata Wachowska, Angelika Muchowicz & Jakub Golab. (2015) Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity. Frontiers in Oncology 5.
Crossref
Crossref
Fabrícia Gimenes, Jorge Juarez Vieira Teixeira, André Luelsdorf Pimenta de Abreu, Raquel Pantarotto Souza, Monalisa Wolski Pereira, Vânia Ramos Sela da Silva, Cinthia Gandolfi Bôer, Silvya Stuchi Maria-Engler, Marcelo Gialluisi Bonini, Sueli Donizete Borelli & Márcia Edilaine Lopes Consolaro. (2014) Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 576-589.
Crossref
Crossref
Tereza Janotová, Marie Jalovecká, Marie Auerová, Ivana Švecová, Pavlína Bruzlová, Veronika Maierová, Zuzana Kumžáková, Štěpánka Čunátová, Zuzana Vlčková, Veronika Caisová, Petra Rozsypalová, Katarína Lukáčová, Nikol Vácová, Markéta Wachtlová, Jiří Salát, Jaroslava Lieskovská, Jan Kopecký & Jan Ženka. (2014) The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model. PLoS ONE 9:1, pages e85222.
Crossref
Crossref
M. K. Misra, S. Prakash, R. Kapoor, S. K. Pandey, R. K. Sharma & S. Agrawal. (2013) Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. Tissue Antigens 82:5, pages 317-326.
Crossref
Crossref
Natalia Aptsiauri, Teresa Cabrera, Angel Garcia-Lora, Francisco Ruiz-Cabello & Federico Garrido. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
253
286
.
Natalia Aptsiauri, Angel Miguel Garcia-Lora & Teresa CabreraNatalia Aptsiauri, Angel Miguel Garcia-Lora & Teresa Cabrera. 2013. MHC Class I Antigens In Malignant Cells. MHC Class I Antigens In Malignant Cells
1
11
.
Aifen Lin, Xia Zhang, Hui‐Hui Xu, Dan‐Ping Xu, Yan‐Yun Ruan & Wei‐Hua Yan. (2011) HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer. International Journal of Cancer 131:1, pages 150-157.
Crossref
Crossref
Robert L. Elliott & Jonathan F. Head. (2012) Cancer: Tumor Iron Metabolism, Mitochondrial Dysfunction and Tumor Immunosuppression; “A Tight Partnership—Was Warburg Correct?”. Journal of Cancer Therapy 03:04, pages 278-311.
Crossref
Crossref
Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson & James P. Allison. (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunological Reviews 241:1, pages 104-118.
Crossref
Crossref
Matthew D. Vesely, Michael H. Kershaw, Robert D. Schreiber & Mark J. Smyth. (2011) Natural Innate and Adaptive Immunity to Cancer. Annual Review of Immunology 29:1, pages 235-271.
Crossref
Crossref
Roy M. Bremnes, Khalid Al-Shibli, Tom Donnem, Rafael Sirera, Samer Al-Saad, Sigve Andersen, Helge Stenvold, Carlos Camps & Lill-Tove Busund. (2011) The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer. Journal of Thoracic Oncology 6:4, pages 824-833.
Crossref
Crossref
Robert L. ElliottXian P. JiangJeffrey T. PhillipsBrian G. BarnettJonathan F. Head. (2011) Human Leukocyte Antigen G Expression in Breast Cancer: Role in Immunosuppression. Cancer Biotherapy and Radiopharmaceuticals 26:2, pages 153-157.
Crossref
Crossref
Eduardo A. Donadi, Erick C. Castelli, Antonio Arnaiz-Villena, Michel Roger, Diego Rey & Philippe Moreau. (2010) Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cellular and Molecular Life Sciences 68:3, pages 369-395.
Crossref
Crossref
A. Lin, C.-C. Zhu, H.-X. Chen, B.-F. Chen, X. Zhang, J.-G. Zhang, Q. Wang, W.-J. Zhou, W. Hu, H.-H. Yang, H.-H. Xu & W.-H. Yan. (2010) Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer. Journal of Cellular and Molecular Medicine 14:9, pages 2318-2329.
Crossref
Crossref
Hai-Xiao Chen, Aifen Lin, Chao-Jun Shen, Rui Zhen, Bao-Guo Chen, Xia Zhang, Fei-Ling Cao, Jian-Gang Zhang & Wei-Hua Yan. (2010) Upregulation of human leukocyte antigen?G expression and its clinical significance in ductal breast cancer. Human Immunology 71:9, pages 892-898.
Crossref
Crossref
A. Lin, H.‐X. Chen, C.‐C. Zhu, X. Zhang, H.‐H. Xu, J.‐G. Zhang, Q. Wang, W.‐J. Zhou & W.‐H. Yan. (2009) Aberrant human leucocyte antigen‐G expression and its clinical relevance in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 14:8, pages 2162-2171.
Crossref
Crossref
Claudia B.M. Bijen, Enja J. Bantema‐Joppe, Renske A. de Jong, Ninke Leffers, Marian J.E. Mourits, Henk F. Eggink, Ate G.J. van der Zee, Harry Hollema, Geertruida H. de Bock & Hans W. Nijman. (2010) The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. International Journal of Cancer 126:6, pages 1417-1427.
Crossref
Crossref
Yong Wook Jung, Young Tea Kim, Sang Wun Kim, Sunghoon Kim, Jae Hoon Kim, Nam Hoon Cho & Jae Wook Kim. (2009) Correlation of Human Leukocyte Antigen-G (HLA-G) Expression and Disease Progression in Epithelial Ovarian Cancer. Reproductive Sciences 16:11, pages 1103-1111.
Crossref
Crossref
A. Ly. (2009) HLA: hommage à Jean Dausset, prix Nobel de médecine (1916–2009)HLA: homage to Jean Dausset, medicine Nobel price (1916–2009). Journal africain du cancer / African Journal of Cancer 1:4, pages 183-187.
Crossref
Crossref
B.-L. Li, A. Lin, X.-J. Zhang, X. Zhang, J.-G. Zhang, Q. Wang, W.-J. Zhou, H.-X. Chen, T.-J. Wang & W.-H. Yan. (2009) Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 74:3, pages 213-221.
Crossref
Crossref
Laura Menendez, L DeEtte Walker, Lilya V Matyunina, Kimberly A Totten, Benedict B Benigno & John F McDonald. (2008) Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors. Molecular Cancer 7:1.
Crossref
Crossref
Venkata Suryanarayana, Lakshmi Rao, Murthy Kanakavalli, Venkata Padmalatha, Turalpati Raseswari, Mamata Deenadayal & Lalji Singh. (2008) Association Between Novel HLA-G Genotypes and Risk of Recurrent Miscarriages: A Case-Control Study in a South Indian Population. Reproductive Sciences 15:8, pages 817-824.
Crossref
Crossref
Inès Zidi & Aghleb Bartegi. (2008) Importance de HLA-G dans les stratégies thérapeutiques anti-cancéreuses. Therapies 63:4, pages 327-332.
Crossref
Crossref
W.-H. Yan, A. Lin, B.-G. Chen, W.-D. Luo, M.-Z. Dai, X.-J. Chen, H.-H. Xu & B.-L. Li. (2008) Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine 12:3, pages 889-898.
Crossref
Crossref
Akiko Ishitani, Noriko Sageshima, Mari Nakanishi & Katsuhiko Hatake. (2008) Can Soluble HLA-G Protein Be a Marker for the Selection of IVF Embryos. Journal of Mammalian Ova Research 25:1, pages 17-25.
Crossref
Crossref
Mirjana Urosevic & Reinhard Dummer. (2008) Human Leukocyte Antigen–G and Cancer Immunoediting. Cancer Research 68:3, pages 627-630.
Crossref
Crossref
Barbara Seliger & Gerald Schlaf. (2007) Structure, expression and function of HLA-G in renal cell carcinoma. Seminars in Cancer Biology 17:6, pages 444-450.
Crossref
Crossref
A. Lin, W.-H. Yan, H.-H. Xu, M.-F. Gan, J.-F. Cai, M. Zhu & M.-Y. Zhou. (2007) HLA-G expression in human ovarian carcinoma counteracts NK cell function. Annals of Oncology 18:11, pages 1804-1809.
Crossref
Crossref
Noriko Sageshima, Takanori Shobu, Keiko Awai, Hiratsugu Hashimoto, Masanori Yamashita, Nobuyoshi Takeda, Yasushi Odawara, Mari Nakanishi, Katsuhiko Hatake & Akiko Ishitani. (2007) Soluble HLA-G is absent from human embryo cultures: A reassessment of sHLA-G detection methods. Journal of Reproductive Immunology 75:1, pages 11-22.
Crossref
Crossref
Jeremy B. Swann & Mark J. Smyth. (2007) Immune surveillance of tumors. Journal of Clinical Investigation 117:5, pages 1137-1146.
Crossref
Crossref
Mark D. Crew. (2007) Play it in E or G: utilization of HLA-E and -G in xenotransplantation. Xenotransplantation 14:3, pages 198-207.
Crossref
Crossref
Alexandre Iannello, Olfa Débbeche, Suzanne Samarani, Sébastien Sabbagh, Michel Duval & Ali Ahmad. (2007)
Le
natural killer
, fer de lance des futures immunothérapies anti-tumorales ?
. médecine/sciences 23:5, pages 502-508.
Crossref
Crossref